Left ventricular assist device-related infections: does the time of onset matter?

被引:0
作者
Amy L. Lehnert
Amanda Hart
Sara D. Brouse
Richard J. Charnigo
Sarah Branam
Maya E. Guglin
机构
[1] University of Kentucky HealthCare,Department of Pharmacy Services
[2] University of Kentucky,Division of Cardiology, Gill Heart Institute
[3] University of Kentucky College of Pharmacy,Department of Pharmacy Practice and Science
来源
Journal of Artificial Organs | 2019年 / 22卷
关键词
Ventricular assist device; LVAD; Infection;
D O I
暂无
中图分类号
学科分类号
摘要
A frequent complication of left ventricular assist devices (LVAD) is the LVAD-associated infections (LVADIs). Contamination may occur during initial surgery/admission or at a later time. We studied the clinical manifestations and outcomes of LVADIs depending on the time of the onset. Patients implanted with LVADs at our institution between August 2009 and December 2014 were included. Patients were stratified into 2 groups based on whether the infection occurred early (< 180 days) or late (≥ 180 days) after LVAD implantation. Out of 37 overall LVADI episodes, 16 (43%) and 21 (57%) occurred early or late after device implantation, respectively. Median time to first LVADI was 88 ± 35 vs. 456 ± 187 days between groups. While superficial driveline-related infection was the most common LVADI type for both groups (56 vs. 71%, p = 0.489), driveline drainage was more prevalent in the late group (24 vs. 69%; p = 0.009). Early LVADIs involved more gram-positive flora, mostly Staphylococcus aureus (69 vs. 33%, p = 0.049), whereas late LVADIs involved more gram-negative pathogens, mostly Pseudomonas aueroginosa (25 vs. 57%; p = 0.045). High rates of treatment failure were consistent between groups (88 vs. 71%, p = 0.384). Compared with superficial LVADI, deeper infections were associated with an increase in mortality (13 vs 46%, p = 0.046). We concluded that early onset with likely in-hospital contamination involved more gram-positive flora, whereas late infection involved more gram-negative flora. Regardless of timing, success of antibacterial treatment was dismal, and infection depth correlated with poorer outcomes.
引用
收藏
页码:98 / 103
页数:5
相关论文
共 42 条
  • [1] Spelman D(2012)Ventricular assist device infections Curr Infect Dis Rep 14 359-366
  • [2] Esmore D(2005)Left ventricular assist device-related infection: treatment and outcome Clin Infect Dis 40 1108-1115
  • [3] Simon D(2001)Long-term use of a left ventricular assist device for end-stage heart failure N Eng J Med 345 1435-1443
  • [4] Fischer S(2011)Working formulation for the standardization of definitions of infections in patients using ventricular assist devices J Heart Lung Transpl 30 375-384
  • [5] Grossman A(2013)Clinical manifestations and management of left ventricular assist device-associated infections Clin Infect Dis 57 1438-1448
  • [6] Rose EA(2015)Left ventricular assist device driveline infections: recent advances and future goals J Thorac Dis 7 2151-2157
  • [7] Gelijns AC(2013)Prospective, multicenter study of ventricular assist device infections Circulation 127 691-702
  • [8] Moskowitz AL(2015)Multidrug-resistant organism infections in patients with left ventricular assist devices Tex Heart Inst J 42 522-527
  • [9] Hannan MM(2012)Continuous-flow devices and percutaneous site infections: clinical outcomes J Heart Lung Transpl 31 1151-1157
  • [10] Husain S(2013)Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality Ann Thorac Surg 95 500-505